Santa Ynez Valley Medical Associates Clinic/Center - Primary Care Medicare: Medicare Enrolled Practice Location: 2030 Viborg Rd, Suite 205, Solvang, CA 93463 Phone: 805-688-2600 Fax: 805-693-8109 |
Sandra Ce Wilson Md Inc Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 680 Alamo Pintado Rd, Suite 202, Solvang, CA 93463 Phone: 805-688-3158 Fax: 805-688-7413 |
Sandra Wilson Md Inc Internal Medicine Medicare: Medicare Enrolled Practice Location: 2030 Viborg Rd, Solvang, CA 93463 Phone: 805-245-9010 Fax: 805-686-9977 |
William J Heringer Md A Professional Medical Corporation Clinic/Center - Primary Care Medicare: Medicare Enrolled Practice Location: 2030 Viborg Rd Ste 201, Solvang, CA 93463 Phone: 805-688-7200 Fax: 805-688-2894 |
Pacific Central Coast Health Centers Clinic/Center - Community Health Medicare: Not Enrolled in Medicare Practice Location: 1992 Old Mission Dr Ste 140, Solvang, CA 93463 Phone: 805-739-3981 Fax: 805-739-3982 |
Santa Ynez Professional Clinic Clinic/Center Medicare: Medicare Enrolled Practice Location: 2040 Viborg Rd Ste 110, Solvang, CA 93463 Phone: 805-686-3971 |
News Archive
Golden Meditech Holdings Limited, China's leading integrated healthcare enterprise, is pleased to announce that the Group will acquire the remaining interests in the Group's Chinese herbal medicine business for a total consideration of HK$90 million in shares.
To continue its commitment to advancing medical imaging technology and improving diagnosis, Toshiba America Medical Systems, Inc. introduces Low-Contrast Imaging (LCI) for Toshiba's InfinixTM-i systems with mid (12" x 12") and large (12" x 16") flat-panel detectors (FPD). Toshiba will demonstrate its low-contrast imaging capabilities at this year's Transcatheter Cardiovascular Therapeutics (TCT) annual meeting in San Francisco, Sept. 21 – Sept. 25, 2009 (Booth #705).
Lawmakers seek ways to expand COBRA and address the Medicare doctor payment "fix."
An antibody drug that targets a surface marker on cancer stem cells could offer a promising new therapeutic approach for treating acute myeloid leukemia (AML), a form of blood cancer that affects an estimated 50,000 people in Saudi Arabia.
Acute myeloid leukemia (AML) is an aggressive cancer known for drug resistance and relapse. In an effort to uncover new treatment strategies, researchers at University of California San Diego School of Medicine and Moores Cancer Center discovered that a cell surface molecule known as CD98 promotes AML.
› Verified 2 days ago